Tuesday, August 11, 2026

How Vieworks Plans to Boost Shareholder Value with 12.4% Dividend Increase in 2026

Vieworks plans to enhance corporate value through growth strategies, increased dividends, and share buybacks to boost shareholder returns.

AWS lights up Korean dev scene with GenAI Amazon Q

AWS enhances its generative AI service, Amazon Q Developer, to support Korean, aiding local developers in various tasks.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

Tag: AACR

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

Unlocking Cancer Treatment: How TXN12923 Targets ULK1 for Enhanced Drug Sensitivity

Txinno Bioscience to present TXN12923, a novel ULK1 targeted protein degrader, at AACR, aiming to enhance cancer treatment efficacy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.